Document is current
Any future updates will be listed below
-
Authors
Schmallenbach, Leo https://orcid.org/0000-0001-5302-2578
Bley, Maximilian https://orcid.org/0000-0003-3019-8727
Bärnighausen, Till W. https://orcid.org/0000-0002-4182-4212
Sugimoto, Cassidy R. https://orcid.org/0000-0001-8608-3203
Lerchenmüller, Carolin https://orcid.org/0000-0002-5620-0285
Lerchenmueller, Marc J. https://orcid.org/0000-0001-8875-3602
-
Funding
Funding for this research was provided by:
Helmholtz Information and Data Science School for Health
Dr. Hans Riegel Foundation
- License Information
-
More Information
Article History
Received: 27 February 2025
Accepted: 28 July 2025
First Online: 27 August 2025
Competing interests
: M.J.L. is a co-founder and shareholder of AaviGen, a cardiovascular gene therapy company. The present study is not related to the company. The other authors declare no competing interests.
